Despite thousands of women founding and leading beauty brands across the UK, the manufacturing side of the cosmetics industry ...
Future Pak becomes exclusive U.S. marketer for Mytesi® and Canalevia®-CA1 Meaningful non-dilutive capital enables Jaguar to focus on its rare-disease pipeline, which is the subject of ongoing BD ...
Phase I human study and preclinical evaluations of OcuRing™-K showed no treatment-related safety concerns, supporting ...
As Indian pharma pivots toward innovation and sustainability, Granules India charts strong growth, R&D and global ambitions ...